KOSDAQBiotech & Pharma468670

Brils

₩10,780▲ 8.67%2026-11-18 close
Market Cap
₩122.5B
Turnover
₩18.5B
Volume
1.6M
Shares out.
11.4M
PER
—
PBR
—
EPS
—
Dividend Yield
—

PER, PBR and dividend yield are calculated from the latest confirmed results (EPS, BPS, dividend per share) and the current share price · Prices as of the 2026-11-18 close

01

Report overview

Export growth, mixed earnings signals

Brils is expanding exports and its North American base and lifting operating profit, yet cumulative Q3 2026 net income fell and the share price trades well below its IPO price.

  1. 1

    On a DART basis, cumulative Q3 2026 revenue reached KRW 6.43 billion, up 17.1% year on year.

  2. 2

    Operating profit rose 52.1% to KRW 746 million, outpacing revenue, while net income fell 52.2% to KRW 157 million.

  3. 3

    According to company press releases, export revenue reached KRW 9 billion, up 50%, with the export share at 44.7%.

  4. 4

    The company set up a Michigan subsidiary in April 2026 to build a North American production base.

  5. 5

    The share price of KRW 10,890 sits below the KRW 19,500 IPO price, after reported single-day moves of 16% to 21%.

02

Business structure

Brils was founded in 2015 as a robot modular platform company and says it internalizes the full chain from system design and hardware manufacturing to software development, installation, and after-sales service.

Its core is a library of more than 100 robot modular platforms, which it combines with standardized modules to fit each customer site and then applies repeatedly across industries and processes. The company reports having carried out 1,499 projects based on these platforms from 2020 through Q3 2026.

Its main customers are global automotive and parts plants, where demand for automation in assembly, inspection and logistics forms the revenue base. Cumulative Q3 2026 export revenue was reported at KRW 9 billion, up 50% year on year, lifting the export share of sales to 44.7%, 9 percentage points higher.

In North America, it began supplying transfer and logistics robots for medical-use products to US medical device maker AirLife, entering the healthcare market. In April 2026 it established a subsidiary in Grand Rapids, Michigan, and began manufacturing forklift-type AMRs and low-profile AMRs there.

At home, the company planned to add 2,993.52㎡ to its Songdo headquarters plant, bringing its R&D and manufacturing site to 4,654.54㎡. It competes with other robot automation suppliers and differentiates itself through reuse of standardized modules and site-specific configurations.

03

Recent trends

On a DART basis, cumulative Q3 2026 revenue was KRW 6.43 billion, up 17.1% from the same period a year earlier. Operating profit was KRW 746 million, up 52.1%, growing faster than revenue and pointing to better profitability. Net income, however, was KRW 157 million, down 52.2% year on year.

Because operating profit rose while net income fell, something below the operating line appears to have pulled net income down.

A company press release issued on November 16, 2026 reported different figures for the same period, with revenue of KRW 20.1 billion, operating profit of KRW 1.6 billion and net income of KRW 1.1 billion, and net income up 79.4%. Since listing, the share price has moved sharply.

According to press reports, it reached KRW 62,100 intraday on its first day before closing its first trade at KRW 30,650. Later, press reports said the stock rose 20.65% in one session to KRW 19,050 with no disclosure or news behind the move.

On another day it fell 16.84% to KRW 17,380, with no company disclosure reported. The shares now trade at KRW 10,890, down 4.22% on the day and well below the KRW 19,500 IPO price.

04

Outlook

The company presents expansion of North American production and its physical AI robot lineup as its next growth pillars.

It has grown the Michigan subsidiary into a base covering assembly and production, started manufacturing forklift-type AMRs and low-profile AMRs there, and plans to widen the physical AI robot lineup in stages. It also said it plans to build a local production base in Europe.

Press reports said it is in talks to supply US electric vehicle and auto parts companies. The company said IPO proceeds would fund expansion of its R&D center, advancement of physical AI technology, and platform expansion into quadruped and humanoid robots.

Whether these plans convert into revenue growth will be shown by the export share and the quarterly revenue trend. On profitability, rising operating profit alongside falling net income makes costs below the operating line a key variable, along with the overall cost structure.

Across the robot industry, rising R&D spending is seen as weighing on profitability. Share price swings have been large since listing, so changes in trading supply remain a short-term variable. Full-year 2026 results are expected to be disclosed in the annual regular report in early 2027.

05

Bull factors

Export and North American expansion

According to company press releases, cumulative Q3 2026 export revenue reached KRW 9 billion, up 50%, lifting the export share to 44.7%. Supplying medical logistics robots to US medical device maker AirLife opened the North American healthcare market. The Michigan subsidiary serves as the base for local sales and production.

Operating profit growth ahead of sales

On a DART basis, cumulative Q3 2026 operating profit rose 52.1% to KRW 746 million, against 17.1% revenue growth. The company's press release described its operating margin as up about 0.7 percentage points year on year. The company also said its revenue grew at an average annual rate above 50% over the past five years.

Platform scale and funding base

Built on more than 100 modular platforms, the company reports 1,499 projects carried out from 2020 through Q3 2026. Standardized modules applied repeatedly across industries are presented as the basis for scaling.

Reports also note cumulative investments of KRW 40.2 billion from POSCO Group, the Korea Development Bank and 22 institutions.

06

Bear factors

Net income decline and earnings quality

On a DART basis, cumulative Q3 2026 net income fell 52.2% to KRW 157 million from the same period a year earlier. Net income declining while operating profit rose indicates that items below the operating line weighed on earnings.

The company's press release reported net income growth of 79.4%, so the two sources point in opposite directions.

Share price volatility and trading below the IPO price

The stock reached KRW 62,100 intraday on its first day before closing its first trade at KRW 30,650, and it now trades at KRW 10,890, well below the KRW 19,500 IPO price. Press reports described single-day moves of 16.84% down and 20.65% up without company disclosures.

Reports also note an institutional lock-up ratio of 21.75%, which cut the free float ratio from 26% to 21% on listing day, a supply factor that can affect the price.

Regulatory and R&D burden

As the US tightened rules on foreign-made robots, the company has responded through its Michigan subsidiary. Depending on the scope of those rules, its export strategy may need adjustment. Across the robot industry, rising R&D spending is seen as making profitability harder to secure.

07

Risk factors

Macro

US rules on foreign-made robots and trade conditions could directly affect the North American sales strategy. With exports at 44.7% of sales, overseas demand conditions pass straight through to results. If automotive capital spending slows at home or abroad, demand for automation could decline in parallel.

Industry and competition

Robot automation requires heavy R&D and changes technology quickly. The company is extending into physical AI, on-device AI and vision-language-action models, but commercialization speed and cost may diverge from plans. If new lineups take time to contribute to profit, cost burdens below operating profit could persist.

Trading and liquidity

The free float shrank after listing and the share price sits below the IPO price, which may increase supply-driven volatility. Single-day moves of 16% to 21% have been reported, creating short-term price risk. Price moves reported without company disclosures also reflect an information gap that adds to volatility risk.

08

Overall view

Brils is widening its exports and North American base around its robot modular platforms, and its cumulative Q3 2026 operating profit rose 52.1% year on year, which shows clear improvement in operating indicators.

Rising export revenue and share, the Michigan subsidiary, and 1,499 projects since 2020 indicate a broadening business base. Net income, however, fell 52.2% over the same period, leaving costs below the operating line and earnings quality as open items.

The gap between the company press release and DART regular report figures is large, and this difference in basis shapes how the earnings trend reads. The share price has moved sharply since listing and now sits below the IPO price, so trading supply and market sentiment carry considerable weight in short-term pricing.

US rules on foreign-made robots and the R&D burden are key variables for both the North American strategy and profitability. Overall, expansion and operating profit gains coexist with the net income decline, price volatility and regulatory risk. The next checkpoints are full-year 2026 results and the operating level of the North American production base.

09

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 11 more articles and sources
  1. newsprime.co.kr
  2. newsprime.co.kr
  3. news.jkn.co.kr
  4. news.jkn.co.kr
  5. newswell.co.kr
  6. newswell.co.kr
  7. ebn.co.kr
  8. mediaic.co.kr
  9. thefairnews.co.kr
  10. ftoday.co.kr
  11. newstong.co.kr

Report written 2026-11-16 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis